Search Results
Mar 12, 2026, 14:42 ET Micro Electrode Array Market to Reach USD 1,991.35 Million by 2032 Amid Rising Neuroscience Research, iPSC-Based Disease Modeling, and High-Density Electrophysiology Adoption - Credence Research
https://www.credenceresearch.com/report/ball-grid-array-bga-packaging-marketActive Phased Array T/R Module Market https://www.credenceresearch.com/report/active-phased-array-t-r-module-marketMicrolens Arrays Market
More news about: Credence Research Inc.
Mar 12, 2026, 12:50 ET Veteran Litigators Nicole T. LeBoeuf and Amy S. Ooi Join Hallett & Perrin
Nicole T. LeBoeuf and
More news about: Hallett & Perrin
Mar 12, 2026, 12:18 ET /C O R R E C T I O N -- Foundation Fighting Blindness/
More news about: Foundation Fighting Blindness
Mar 12, 2026, 11:26 ET Osamu Yada, Personal Trainer for Los Angeles Dodgers Pitcher Yoshinobu Yamamoto, Brings Elite Body Recognition Tech "KINETIC LAB-LINK" to Kickstarter
https://www.dropbox.com/scl/fo/k5139ptqfgrdmdcgnno8f/ADWWumCyP_YyxtxRmU9t2d0?rlkey=09gw2obeu58m15y0t2bja97ey&st=df0sw05f&dl=0KINETIC LAB-LINK on Kickstarter:
More news about: Osamu Yada, Personal Trainer for Dodgers Pitcher Yoshinobu Yamamoto
Mar 12, 2026, 10:59 ET GoodWe reinforce leadership in EU residential energy storage market at launch of world-first certified low-noise solution in Amsterdam
https://mma.prnewswire.com/media/2932731/GoodWe_awarded_world_first_Grade_A_low_noise_performance_certification_ESS_T_V.jpg
More news about: GoodWe
Mar 12, 2026, 10:38 ET Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
lira-cel, an ovarian cancer immunotherapy being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. This technology is differentiated from other cell therapies as the natural ligand of the FSHR receptor, FSH,
More news about: Anixa Biosciences, Inc.
Mar 12, 2026, 10:31 ET Stämm Redefines Biomanufacturing With a Bubble-Free, High-Throughput Bioprocessor Built for Decentralized Production
process development within Research Use Only (RUO) applications. Pharma and biotech teams evaluating Stämm's technologies for pre-clinical production, CAR-T, stem cell expansion, or monoclonal antibody workflows should contact Stämm directly at www.stamm.bio.
More news about: Stämm
Mar 12, 2026, 10:16 ET Global Diagnostic Imaging Equipment Market is Projected to Cross USD 80 Billion by 2034 Due to the Rising Demand for Advanced Imaging Technologies | DelveInsight
Color and unsurpassed quality.In January 2025, Siemens Healthineers unveils Dry Cool technology-enabled and virtually helium-free 1.5T MAGNETOM Flow MRI, the Dual Source CT scanner SOMATOM Pro. Pulse, Digital X-ray systems MULTIX Impact E, and versatile AI-powered Ultrasound systems ACUSON
More news about: DelveInsight Business Research, LLP
Mar 12, 2026, 10:15 ET TRUE RELIGION REUNITES WITH MEGAN THEE STALLION AND DEBUTS KEY GLOCK FOR SPRING 2026 "MAKE IT TRUE" CAMPAIGN
urban casual lifestyle apparel and accessories brand for women, men and kids, quickly became a global icon by redefining fashion with its bold Super T stitching and innovative construction. Worn by artists, athletes and style pioneers, the brand is rooted in self-expression and individuality. Today,
More news about: True Religion
Mar 12, 2026, 10:02 ET Stämm Redefines Biomanufacturing With a Bubble-Free, High-Throughput Bioprocessor Built for Decentralized Production
process development within Research Use Only (RUO) applications. Pharma and biotech teams evaluating Stämm's technologies for pre-clinical production, CAR-T, stem cell expansion, or monoclonal antibody workflows should contact Stämm directly at www.stamm.bio.
More news about: Stämm
Mar 12, 2026, 10:01 ET Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight
(177Lu-PSMA-617, 225Ac‑PSMA‑617, 177Lu-NNS309, 177Lu-NeoB, AAA614, and ESP359), Curium Pharma (177Lu-PSMA-I&T), Lantheus and Eli Lilly and Company (Lu-PNT2002 and LNTH-1095), Fusion Pharmaceuticals and AstraZeneca (FPI-2265), Clarity Pharmaceuticals (67CU
More news about: DelveInsight Business Research, LLP
Mar 12, 2026, 10:00 ET Breakthrough T1D Chief Medical Officer Dr. Thomas Danne to be Honored with Children with Diabetes President's Award for Innovation
advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition.About type 1 diabetes (T1D)T1D is an autoimmune condition that causes the pancreas to make very little insulin
More news about: Breakthrough T1D, Formerly JDRF
Mar 12, 2026, 10:00 ET Eoptolink Demos IMDD 400G per Lambda Based 1.6T DR4 Optical Transceiver Solution at OFC 2026
reflected in the roadmap for high-speed optical transceivers, progressing toward 800G, 1.6T, and 3.2T.Currently, 100G/lambda-based 800G optical transceivers are being deployed in high volumes, while 200G/lambda-based 1.6T products are ramping up. At the same time, the industry is accelerating the development
More news about: Eoptolink Technology Inc., Ltd.
Mar 12, 2026, 10:00 ET T. ROWE PRICE LAUNCHES ITS FIRST EMERGING MARKETS EQUITY ETF OFFERING
lineup expands to 32 with today's addition of the T. Rowe Price Emerging Markets Equity Research ETF, which began trading todayBALTIMORE, March 12, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm
More news about: T. Rowe Price Group
Mar 12, 2026, 10:00 ET Eoptolink Joins XPO MSA and Unveils Industry-First 12.8 Tbps Liquid-Cooled Pluggable Optics for AI Data Centers
optical interconnect solutions for AI infrastructure and cloud data centers.Eoptolink will be showcasing its latest 12.8T XPO, 400G/lambda-1.6T DR4, and 200G/lambda-1.6T FRO/LRO/LPO series optical transceiver solutions at the Eoptolink booth #1211 during OFC 2026 in Los Angeles, CA. Visitors are
More news about: Eoptolink Technology Inc., Ltd
Mar 12, 2026, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR
to treat autoimmune disorders. The Company's lead product candidateis rezpegaldesleukin (a/k/a REZPEG or NKTR-358), a novel, first-in-class regulatory T cell stimulator for the treatment of, inter alia, alopecia areata.In March 2024, Nektar initiated its Phase 2b REZOLVE-AA trial, which was
More news about: Pomerantz LLP
Mar 12, 2026, 09:42 ET NewPhotonics® Introduces Industry First 3.2Tbps DR8 Transmitter-on-Chip PIC with Integrated OSPic™ Optical Signal Processor for AI Data Center Connectivity
lane. "AI clusters are rapidly driving the transition to higher-speed optical interconnects, with the industry moving from 800G and 1.6T to 3.2T in the next phase of scaling," said Vlad Kozlov, Founder, LightCounting. "Highly integrated photonic engines that combine lasers, modulators
More news about: NewPhotonics Ltd
Mar 12, 2026, 09:38 ET NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
induction treatment period of the Phase 2b REZOLVE-AA trial of investigational rezpegaldesleukin, a first-in-class IL-2 pathway agonist and regulatory T-cell (Treg) proliferator." The press release disclosed that the trial failed to reach statistical significance, which Nektar attributed to the inclusion
More news about: Faruqi & Faruqi, LLP
Mar 12, 2026, 09:26 ET 醫學人工智能研討會推動負責任的運用與創新
醫學博士、哲學博士說：「我們希望分享耶魯及其他機構正在進行、非常振奮人心的研究。 我們將討論在轉化研究（即快將應用到醫療服務的研究）中，開發、評估和應用 AI 等重要議題的最佳實踐方案，並計劃開展合作，攜手推進我們現有的工作。」是次研討會旨在促進耶魯大學校內不同的研究團隊，與其他機構的研究團隊建立聯繫。 耶魯醫學院 Robert T. McCluskey 生物醫學資訊學與數據科學教授兼研討會聯合創辦人 Hua Xu 博士說：「屆時將有講者探討 AI 在臨床的實際應用，例如怎樣將
More news about: Yale School of Medicine
Mar 12, 2026, 09:15 ET A2GOLD OUTLINES 2026 EXPLORATION PLANS TO EXPAND SILVER AND GOLD RESOURCES AT THE TAYLOR PROJECT, NEVADA
corridorChannel samples returning up to 4.2 g/t gold over 11.0 meters, including 7.1 g/t gold over 3.3 metersSPT-66 intersected 1.02 g/t gold over 18.3 meters starting at surfaceSPT-65 intersected 0.68 g/t gold over 24.4 meters starting at surface including 0.85 g/t gold over 12.2 metersQUALIFIED
More news about: A2 Gold Corp
Mar 12, 2026, 09:15 ET NatGold Digital Signs $20M Definitive Agreement to Acquire Historic Idaho Gold Project, Targeting 73% Token Minting Share
exploration and development dating back more than a century.The project area lies within multiple township sections spanning T28N R8E, T28N R7E, T27N R8E, T27N R7E, and T26N R7E, with the geographic center located at 2,013,054 Easting and 16,607,230 Northing (NAD83, Zone 11 BLM US Feet). Mapping coverage
More news about: NatGold Digital Ltd.
Mar 12, 2026, 09:01 ET MetaVia Expands Global Patent Protection for Vanoglipel, Supporting Metabolic and Liver Disease Therapy Through 2035
pre-clinical animal models of MASH and T2D where vanoglipel reduced hepatic steatosis, inflammation, fibrosis, and improved glucose control. Furthermore, in Phase 1a, 1b and 2a trials, vanoglipel was well tolerated in both healthy volunteers and those with T2DM. In a Phase 2a clinical study, vanoglipel
More news about: MetaVia Inc.